Invests in
Sectors:
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
Lists including Uciane
Investments
Work Experience
2025
Stealth
2025
2021 - 2024
Principal
2021 - 2024
Fund management - oversaw INV fund ($100M) Company Creation/Operations/Financing: ashibio (Head Corp Dev), Crane BioTherapeutics (interim CEO) Boards: Crane BioTherapeutics, TUO Therapeutics, ProRavel
2019 - 2021
Principal
2019 - 2021
Fund management - co-lead life science vertical (2/3 of fund), company creation, portfolio management Company Creation/Operations/Financing: T-Cypher Bio (interim Exec Chair), PepGen, ORFonyx, Alethiomics, Endlyz Boards: T-Cypher Bio, PepGen (NASDAQ: PEPG), Miro Bio (acq. by Gilead), DJS (acq. by AbbVie), Scenic Bio
2018 - 2019
Associate
2018 - 2019
Life science investing, company creation, portfolio company operations. Company Creation/Board: Dyne Therapeutics, Quench Bio, Navitor Operations: Dyne Therapeutics, Quench Bio, Korro Bio, AVRO BIO
2016 - 2018
Director of Business Development & Strategy
2016 - 2018
Drove business development & corporate/pipeline strategy; participated in venture financing; conceptualized strategic academic partnership; presented to BoD; engaged with various bankers, analysts, VCs
2011 - 2016
Manager | Consultant | Associate
2011 - 2016
Corporate/pipeline strategy, early commercial strategy, business development; strong oncology focus Drove internal initiatives geared towards growing Clarion's oncology business Published two articles (business journal & peer-reviewed journal) in oncology
2011 - 2011
Postdoctoral Fellow
2011 - 2011